SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced ...

According to DelveInsight's analysis, the primary sclerosing cholangitis market is anticipated to grow during the forecast period (2025--2034), driven by the launch of emerging therapies such as LB-P8 ...

Shift work and irregular eating patterns could affect liver function and disrupt its delicate circadian rhythm, University of Queensland researchers have found. Dr. Meltem Weger from UQ's Institute ...

The protein, known as plasma fibronectin, is naturally present in blood at higher levels in men than in women, declines when ...

An experimental pill called enlicitide slashed levels of low-density lipoprotein (LDL) cholesterol, commonly known as "bad" ...

MIT engineers designed a type of tissue model that more accurately mimics the architecture of the liver, including blood ...

TFOS DEWS III emphasizes matching dry eye treatments to specific mechanisms such as lipid imbalance, osmolarity, and glycocalyx failure.

Cholestatic liver diseases comprise a heterogeneous group of disorders characterized by impaired bile formation or flow, ...

The novel metabolic predictor emphasizes central adiposity, while integrating metabolites and other measures of metabolic ...

A long-term study found that while a ketogenic diet prevented weight gain, it also triggered major metabolic problems. Mice developed fatty liver disease, abnormal blood fats, and an impaired ability ...

A new study suggests that a naturally occurring compound made by healthy gut bacteria may help protect children from developing fatty liver disease later in life. Children whose mothers eat diets high ...

Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide. Epidemiological evidence indicates that MASLD is associated with an ...